Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 12 03:36PM ET
16.07
Dollar change
-0.08
Percentage change
-0.49
%
IndexRUT P/E- EPS (ttm)-2.74 Insider Own59.89% Shs Outstand170.11M Perf Week0.32%
Market Cap2.75B Forward P/E- EPS next Y-2.87 Insider Trans19.56% Shs Float68.57M Perf Month14.63%
Income-413.84M PEG- EPS next Q-0.70 Inst Own55.66% Short Float31.62% Perf Quarter-14.47%
Sales0.00M P/S- EPS this Y-4.82% Inst Trans24.07% Short Ratio12.31 Perf Half Y-44.00%
Book/sh4.16 P/B3.86 EPS next Y-0.38% ROA-57.32% Short Interest21.68M Perf Year-36.75%
Cash/sh4.18 P/C3.85 EPS next 5Y-1.56% ROE-62.46% 52W Range12.72 - 34.47 Perf YTD-35.12%
Dividend Est.- P/FCF- EPS past 5Y-12.18% ROIC-58.50% 52W High-53.38% Beta0.62
Dividend TTM- Quick Ratio11.16 Sales past 5Y- Gross Margin- 52W Low26.35% ATR (14)0.86
Dividend Ex-Date- Current Ratio11.16 EPS Y/Y TTM-44.95% Oper. Margin- RSI (14)56.22 Volatility4.06% 2.80%
Employees362 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.33 Target Price43.67
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-23.20% Payout- Rel Volume0.93 Prev Close16.15
Sales Surprise- EPS Surprise10.28% Sales Q/Q- EarningsMay 29 BMO Avg Volume1.76M Price16.07
SMA205.78% SMA507.34% SMA200-29.90% Trades Volume1,536,347 Change-0.49%
Date Action Analyst Rating Change Price Target Change
Mar-03-25Initiated Jefferies Hold $20
Jan-03-25Downgrade Wolfe Research Outperform → Peer Perform
Oct-10-24Resumed Raymond James Outperform $36
Oct-09-24Reiterated Oppenheimer Outperform $47 → $53
Mar-28-24Initiated Oppenheimer Outperform $50
Mar-13-24Initiated Goldman Buy $50
Feb-20-24Initiated JP Morgan Overweight $51
Feb-15-24Initiated Wolfe Research Outperform $55
Dec-12-23Initiated Deutsche Bank Buy $50
Oct-13-23Upgrade UBS Neutral → Buy $18 → $55
Jun-02-25 12:00PM
May-30-25 08:59AM
May-29-25 07:00AM
May-09-25 09:02AM
Apr-22-25 06:00AM
04:08PM Loading…
Apr-21-25 04:08PM
10:18AM
07:00AM
07:00AM
Apr-08-25 10:05AM
Mar-24-25 01:56PM
Mar-21-25 12:17PM
Mar-20-25 12:30PM
10:19AM
09:05AM
05:07PM Loading…
Mar-19-25 05:07PM
04:04PM
01:12PM
12:39PM
09:26AM
07:45AM
07:45AM
Mar-18-25 04:32PM
Mar-05-25 07:13PM
Mar-04-25 04:50PM
Feb-23-25 01:33PM
Feb-22-25 12:53AM
Feb-19-25 04:49PM
Feb-12-25 10:00AM
09:35AM
11:57PM Loading…
Feb-10-25 11:57PM
Feb-06-25 06:30AM
Jan-30-25 05:03PM
Jan-17-25 11:10AM
Jan-16-25 08:45AM
Jan-13-25 08:00AM
Dec-20-24 07:20AM
Nov-21-24 05:31PM
Nov-13-24 03:05AM
Nov-07-24 06:30AM
Oct-29-24 06:30AM
Oct-01-24 09:58AM
Sep-30-24 11:12AM
Sep-09-24 12:54PM
09:13AM
07:00AM
03:55AM
Sep-05-24 11:31AM
06:30AM
Aug-09-24 12:20AM
Aug-06-24 04:05PM
Jun-28-24 11:30AM
May-31-24 08:04AM
02:26AM
May-30-24 04:02PM
11:29AM
07:22AM
05:53AM
May-29-24 09:53PM
04:06PM
04:01PM
10:17AM
May-27-24 06:28PM
May-13-24 09:55AM
May-08-24 02:43AM
Apr-24-24 11:33AM
07:39AM
Apr-22-24 11:53AM
Apr-17-24 12:00PM
Mar-25-24 03:00PM
Mar-21-24 04:45PM
11:31AM
Mar-17-24 05:20PM
Mar-14-24 07:04AM
Mar-13-24 11:30AM
Mar-12-24 07:30AM
Mar-08-24 09:35AM
Feb-26-24 03:04PM
Feb-23-24 11:22PM
Feb-14-24 04:35AM
12:29AM
Feb-13-24 07:26AM
Feb-12-24 07:00AM
Feb-06-24 02:38PM
Jan-22-24 06:07AM
Jan-19-24 04:39PM
Jan-13-24 03:02AM
Jan-03-24 08:00AM
Dec-26-23 10:01AM
Dec-21-23 04:09PM
11:00AM
10:57AM
06:49AM
Dec-20-23 04:30PM
04:30PM
Dec-19-23 10:16AM
Dec-01-23 01:01AM
Nov-29-23 10:22AM
Nov-28-23 07:00AM
07:00AM
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLIAM MACIASOfficerJun 03 '25Proposed Sale15.6180,0001,248,616Jun 03 05:42 PM
GEORGE V MIGAUSKYFormer DirectorMay 21 '25Proposed Sale14.5821,812318,047May 21 04:24 PM
GEORGE V MIGAUSKYFormer DirectorMay 19 '25Proposed Sale14.5828,188410,908May 19 04:40 PM
Stout Jay SChief Technology OfficerApr 23 '25Sale14.791,92528,471209,243Apr 25 04:17 PM
Geffner MichaelChief Medical OfficerApr 23 '25Sale14.792,34934,742225,370Apr 25 04:15 PM
Barnett Eva ReneeChief Financial OfficerApr 16 '25Sale14.892,99344,566396,774Apr 17 04:08 PM
Salzmann PeterChief Executive OfficerApr 16 '25Sale14.898,321123,9001,178,191Apr 17 04:07 PM
Salzmann PeterChief Executive OfficerApr 09 '25Sale12.9928,094364,9411,186,512Apr 11 04:05 PM
Fromkin Andrew J.DirectorMar 07 '25Sale19.608,000156,76991,913Mar 11 04:18 PM
ANDREW J FROMKINDirectorMar 07 '25Proposed Sale19.528,000156,160Mar 07 04:17 PM
Macias William L.Chief Medical OfficerFeb 19 '25Sale20.862,05542,867357,353Feb 21 04:06 PM
Barnett Eva ReneeChief Financial OfficerFeb 19 '25Sale20.862,81458,700321,952Feb 21 04:05 PM
Salzmann PeterChief Executive OfficerFeb 19 '25Sale20.8615,439322,058948,786Feb 21 04:04 PM
MARK S LEVINEFormer AffiliateFeb 14 '25Proposed Sale20.1669,7631,406,757Feb 14 04:11 PM
MARK S LEVINEFormer AffiliateFeb 11 '25Proposed Sale19.5429,196570,437Feb 11 04:11 PM
Stout Jay SChief Technology OfficerJan 22 '25Sale23.592,19551,780139,991Jan 24 04:23 PM
Geffner MichaelChief Medical OfficerJan 22 '25Sale23.592,65762,679132,314Jan 24 04:22 PM
Macias William L.Chief Medical OfficerJan 15 '25Sale23.832,38356,782359,408Jan 17 04:07 PM
Barnett Eva ReneeChief Financial OfficerJan 15 '25Sale23.832,29854,757324,766Jan 17 04:05 PM
Salzmann PeterChief Executive OfficerJan 15 '25Sale23.838,767208,900964,225Jan 17 04:04 PM
Roivant Sciences Ltd.DirectorJan 13 '25Buy20.0016,845,010336,900,20096,650,341Jan 15 04:36 PM
Barnett Eva ReneeChief Financial OfficerJan 08 '25Sale24.104,10598,930327,064Jan 10 04:12 PM
Salzmann PeterChief Executive OfficerJan 08 '25Sale24.105,105123,030972,992Jan 10 04:11 PM
Pande AtulDirectorDec 02 '24Sale28.547,750221,18586,663Dec 04 04:22 PM
Hughes Douglas J.DirectorDec 02 '24Sale28.545,425154,830119,585Dec 04 04:20 PM
DOUGLAS J. HUGHESOfficerDec 02 '24Proposed Sale28.205,425152,985Dec 02 04:33 PM
ATUL CHANDRA PANDEDirectorDec 02 '24Proposed Sale28.207,750218,550Dec 02 04:33 PM
Levine Mark S.Chief Legal OfficerNov 20 '24Sale25.453,65092,892319,228Nov 22 04:12 PM
Macias William L.Chief Medical OfficerNov 20 '24Sale25.453,35385,334361,791Nov 22 04:11 PM
Barnett Eva ReneeChief Financial OfficerNov 20 '24Sale25.454,174106,228331,169Nov 22 04:09 PM
Salzmann PeterChief Executive OfficerNov 20 '24Sale25.4516,692424,811978,097Nov 22 04:08 PM
Levine Mark S.Chief Legal OfficerOct 23 '24Sale29.534,361128,780322,878Oct 25 04:25 PM
Geffner MichaelChief Medical OfficerOct 23 '24Sale29.533,18994,171134,971Oct 25 04:23 PM
Stout Jay SChief Technology OfficerOct 23 '24Sale29.532,74080,912142,186Oct 25 04:21 PM
Salzmann PeterChief Executive OfficerOct 16 '24Sale28.799,095261,845994,789Oct 18 04:31 PM
Macias William L.Chief Medical OfficerOct 16 '24Sale28.793,18891,783365,144Oct 18 04:30 PM
Levine Mark S.Chief Legal OfficerOct 16 '24Sale28.792,86082,339327,239Oct 18 04:28 PM
Barnett Eva ReneeChief Financial OfficerOct 16 '24Sale28.793,27194,172335,343Oct 18 04:27 PM
Barnett Eva ReneeChief Financial OfficerOct 09 '24Sale29.565,162152,589338,614Oct 11 04:04 PM
Salzmann PeterChief Executive OfficerOct 09 '24Sale29.564,460131,8381,003,884Oct 11 04:02 PM
Levine Mark S.Chief Legal OfficerAug 21 '24Sale31.863,295104,976330,099Aug 23 04:15 PM
Macias William L.Chief Medical OfficerAug 21 '24Sale31.863,02796,437368,332Aug 23 04:14 PM
Barnett Eva ReneeChief Financial OfficerAug 21 '24Sale31.863,768120,045343,776Aug 23 04:11 PM
Butchko Julia G.Chief Development OfficerAug 21 '24Sale31.863,02796,437440,959Aug 23 04:10 PM
Salzmann PeterChief Executive OfficerAug 21 '24Sale31.8615,068480,0521,008,344Aug 23 04:07 PM
Stout Jay SChief Technology OfficerJul 24 '24Sale27.762,81378,089144,926Jul 26 04:20 PM
Geffner MichaelChief Medical OfficerJul 24 '24Sale27.763,45695,939138,160Jul 26 04:19 PM
Levine Mark S.Chief Legal OfficerJul 24 '24Sale27.764,015111,456333,394Jul 26 04:17 PM
Levine Mark S.Chief Legal OfficerJul 17 '24Sale29.692,50574,382337,409Jul 19 05:42 PM
Macias William L.Chief Medical OfficerJul 17 '24Sale29.693,04490,386371,359Jul 19 05:41 PM
Barnett Eva ReneeChief Financial OfficerJul 17 '24Sale29.693,12392,733347,544Jul 19 05:39 PM
Butchko Julia G.Chief Development OfficerJul 17 '24Sale29.692,86785,132443,986Jul 19 05:38 PM
Salzmann PeterChief Executive OfficerJul 17 '24Sale29.698,685257,8871,023,412Jul 19 05:36 PM
Barnett Eva ReneeChief Financial OfficerJul 09 '24Sale28.064,747133,201350,667Jul 10 05:07 PM
Butchko Julia G.Chief Development OfficerJul 09 '24Sale28.061,52742,848446,853Jul 10 05:06 PM
Salzmann PeterChief Executive OfficerJul 09 '24Sale28.064,619129,6091,032,097Jul 10 05:04 PM